首页   >  
Angiogenesis/Protein Tyrosine Kinase
  >  
Trk Receptor
  • c Met
  • VEGFR
  • Tie2
  • FLT3
  >   奥曲替尼
Altiratinib 结构式

奥曲替尼

参考资料 仅供科学研究,不可用于个人用途。
货号 :BCP15682CAS号 :1345847-93-9纯度:98%
全国免运费!免费咨询:400-099-8200 或 手机联系:13472751340
即时询价 ×

* 必填项

请填妥以下表格,您将在一分钟内得到邮件机器人给你的报价。

Product name

 

* Applicant name

Catalog Number

 

* Institution/Company

* Email address

 

Phone number

Country

 

* Quantity Required

Remarks

Inquiry Online ×

* Required Fields.

Please complete the form below and we will contact you shortly.

Product name

 

* Applicant name

Catalog Number

 

* Institution/Company

* Email address

 

Phone number

Country

 

* Quantity Required

Remarks

Bulk Inquiry ×

* Required Fields.

Please complete the form below and we will contact you shortly.

Product name

 

* Applicant name

Catalog Number

 

* Institution/Company

* Email address

 

Phone number

Country

 

* Quantity Required

Remarks

  • 基本信息与产品描述
CAS号 1345847-93-9 货号 BCP15682
中文名 奥曲替尼
英文名 Altiratinib
中文别名
英文别名 DCC-2701;DCC 2701;DCC2701; DP 5164; DP5164; DP-5164;
SMILES C1CC1C(=O)NC2=NC=CC(=C2)OC3=C(C=C(C(=C3)F)NC(=O)C4(CC4)C(=O)NC5=CC=C(C=C5)F)F
化学名称
分子式 C26H21F3N4O4 分子量 510.64
纯度 98% 配送 惯例下常温包邮
产品描述 Altiratinib, also known as DCC-270, DP-5164, is an oral, selective and highly potent inhibitor of MET, TIE2, VEGFR2 and TRK kinases with potential anticancer activity. DCC-2701 effectively reduces tumor burden in vivo and blocks c-MET pTyr(1349)-mediated signaling, cell growth and migration as compared with a HGF antagonist in vitro. Importantly, DCC-2701's anti-proliferative activity was dependent on c-MET activation induced by stromal human fibroblasts and to a lesser extent exogenous HGF.
  • 技术资料和支持
在购买和使用瀚香生物产品的过程中,您遇到的任何问题,都可以咨询我们的免费热线:400-099-8200,或者和我们的客服 。 我们竭诚解决您的一切疑惑,保证您的舒心顺畅。

相关产品推荐

查看更多 >

Tags:Altiratinib 供应商,Altiratinib 购买,Altiratinib 生产,Altiratinib 批量,Altiratinib 供应,Altiratinib 订购,Altiratinib 采购

2853530910